Beans may sometimes give you gas, but one expert says that shouldn’t stop you from finding ways to include them in your diet. Why? Because they are packed with nutrients that contribute to good health. “Beans are in a unique category because they are a protein source, but they are also complex carbohydrates,” said Dr.…  read on >  read on >

Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same hormone associated with blood sugar and appetite, a new study finds. Ozempic and Wegovy (semaglutide) promoted the loss of 10% or more body weight in 61% of people being treated for obesity and 23% being treated for diabetes after a…  read on >  read on >

Excessive time spent on social media increases children’s and teens’ risk of developing an eating disorder, a new study warns. Each additional hour of total screen time or social media use raises the likelihood that a kid or young teen will have eating disorder symptoms two years later, researchers reported recently in the journal Eating…  read on >  read on >

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval. All doses of tirzepatide consistently reduced weight in both women and men, researchers found. But women lost up to 25% of their initial body weight when treated…  read on >  read on >

Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney disease, a new clinical trial shows. The drugs’ active ingredient, semaglutide, reduced heart health risk by 20% in heavyset people who took it for more than three years, researchers reported Wednesday at the European Association for…  read on >  read on >

The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report. The findings, published Tuesday in the New England Journal of Medicine and presented simultaneously at the European Association for the Study of Diabetes annual meeting in Madrid, are the first to demonstrate the effects of liraglutide (Saxenda) on children…  read on >  read on >